Entering the EU Market: Turning Regulatory Complexity into Strategic Control

Entering the EU market is about more than understanding MDR and IVDR. For non-EU medical device manufacturers, the real challenge is building the regulatory control needed to navigate a complex market, maintain compliance and keep commercial plans on track.

This white paper explores why capable organizations still encounter friction in the EU, what MDR and IVDR have changed in practice, and how stronger alignment between evidence, ownership and lifecycle activities can make market access more predictable.

What you’ll learn

• Why EU market access is a lifecycle challenge, not just a submission exercise
• Where non-EU manufacturers commonly run into difficulties
• What separates a weak EU market model from a strong one
• How to build stronger regulatory and operational control
• Why audit readiness, evidence maturity and cross-functional alignment matter
• How the right regulatory expertise can reduce rework, uncertainty and avoidable delays